|
THE SIMPLE FACTSTM...Trasylol, also known as aprotinin, has been in use worldwide since the 1990s to reduce bleeding related to heart bypass surgery (CABG).
Based on the latest data, it appears that over four and a half million people had been given the drug Trasylol, and over a million were in the United States. Trasylol is made by Bayer AG.
TRASYLOL: When is it used?
Trasylol is used during open heart surgery, heart bypass, heart valve replacement and other cardiac surgery to control bleeding.
TRASYLOL: What do leading medical journals say?
A major study recently published in the New England Journal of Medicine found that Trasylol significantly raised the risk of death compared to competing products and that patients given Trasylol had a more than 50 percent higher death rate than patients who were given alternative, cheaper blood clotting drugs.
TRASYLOL: What does the FDA say?
The FDA, pressured Bayer AG to suspend sales of Trasylol in November 2007. The FDA, stated that access to the drug will be limited to investigational use for certain patients who have no acceptable alternatives but supports the removal of Trasylol from regular use.
It appears that the patients who received Trasylol were more likely to die than compared to patients who received an alternative drug. The patients who were given Trasylol and died after surgery, usually died of kidney failure, heart failure, heart attacks and/or strokes.
TRASYLOL: What do the major media outlets report?
Recently, a major news television program - 60 Minutes - reported that Bayer AG had been aware of safety concerns and deaths associated with the use of the drug Trasylol.
It appears that Bayer AG conducted its own internal study and found that patients given the drug Trasylol were found to have an elevated risk of death and renal - kidney - failure.
Unfortunately, the drug Trasylol was allowed to remain on the market and was used in countless open heart surgery operations. Based on reports, the use of the drug Trasylol - up until its recall - may have contributed to thousands of unnecessary deaths.
Quite frankly, THE SIMPLE FACTSTM about the Bayer AG drug Trasylol® used during heart surgery and the possible injuries - renal failure, kidney damage, kidney failure, long term dialysis, heart damage, heart failure, heart attack, stroke and possibly death - that may be caused by the use of Trasylol during open heart surgery (CABG) are unacceptable.
We are investigating claims of renal failure, kidney damage, kidney failure, long term dialysis, heart damage, heart failure, heart attack, stroke and death in connection with possible side effects and problems from the use of the drug Trasylol following open heart surgery (CABG).
In addition, an MDL has been setup in the Southern District of Florida for Trasylol litigation (IN RE: Trasylol Products Liability Litigation No. 1928).
We are here to help you protect your legal rights and the legal rights of your loved ones.
|
